Gemcitabine

Last Updated: 09/19/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23620 publications

Purine and pyrimidine analogs differentially regulate cell wall precursor biosynthesis to control β-lactam susceptibility in methicillin-resistant Staphylococcus aureus.

Purine and pyrimidine analogs differentially regulate cell wall precursor biosynthesis to control β-lactam susceptibility in methicillin-resistant Staphylococcus aureus.

Journal: mBio

Published: September 08, 2026

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; sevabertinib for lung cancer, gemcitabine intravesical system and durvalumab for bladder cancer, azacitidine for leukemia, cemiplimab for skin cancer, and ropeginterferon alfa-2b for essential thrombocythemia.

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; sevabertinib for lung cancer, gemcitabine intravesical system and durvalumab for bladder cancer, azacitidine for leukemia, cemiplimab for skin cancer, and ropeginterferon alfa-2b for essential thrombocythemia.

Journal: International journal of clinical oncology

Published: September 06, 2026

Western Blot Analysis of Microtubule-Associated Protein Light Chain 3 to Monitor Autophagosomal Dynamics in Mouse-Derived Pancreatic Cancer Cells.

Western Blot Analysis of Microtubule-Associated Protein Light Chain 3 to Monitor Autophagosomal Dynamics in Mouse-Derived Pancreatic Cancer Cells.

Journal: Journal of visualized experiments : JoVE

Published: September 04, 2026

Correction to "Preoperative Gemcitabine/Nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer: A Comparative Analysis With Preoperative Chemoradiation Therapy Using Gemcitabine Alone".

Correction to "Preoperative Gemcitabine/Nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer: A Comparative Analysis With Preoperative Chemoradiation Therapy Using Gemcitabine Alone".

Journal: Annals of gastroenterological surgery

Published: September 04, 2026

Enhancing Gemcitabine Uptake by Promoting Dimerization of the ENT1 Transporter Improves Sarcoma Patient Response Rate.

Enhancing Gemcitabine Uptake by Promoting Dimerization of the ENT1 Transporter Improves Sarcoma Patient Response Rate.

Journal: The Journal of clinical investigation

Published: September 03, 2026

Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response.

Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response.

Journal: Biomaterials science

Published: September 01, 2026

Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.

Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.

Journal: Leukemia & lymphoma

Published: August 30, 2026

Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.

Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.

Journal: Journal of visualized experiments : JoVE

Published: August 29, 2026

Real-world outcomes of chemoimmunotherapy in advanced biliary tract cancer: a multicenter study with a propensity-matched historical cohort.

Real-world outcomes of chemoimmunotherapy in advanced biliary tract cancer: a multicenter study with a propensity-matched historical cohort.

Journal: ESMO real world data and digital oncology

Published: August 22, 2026

Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM).

Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM).

Journal: JCO oncology advances

Published: August 18, 2026

Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.

Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.

Journal: The Cochrane database of systematic reviews

Published: August 17, 2026

Recurrent Invasive Clear Cell Subtype of Upper Tract Urothelial Carcinoma Responding to Enfortumab Vedotin and Pembrolizumab After Chemotherapy: A Case Report.

Recurrent Invasive Clear Cell Subtype of Upper Tract Urothelial Carcinoma Responding to Enfortumab Vedotin and Pembrolizumab After Chemotherapy: A Case Report.

Journal: Archivos espanoles de urologia

Published: August 17, 2026

Showing 1-12 of 23,620

Last Updated: 09/19/2026